03.03.2023 • News
Aenova Appoints Hanno Scheffczik as Managing Director of its Marburg Site
Hanno Scheffczik has been appointed as the new Managing Director of Temmler Pharma, a member of the Aenova Group. Effective Mar. 1, 2023, he succeeds Alfred Veit, who is retiring.
With around 150 employees, the Aenova site in Marburg manufactures delayed-release tablets and capsules as well as moisture-sensitive dosage forms.
Scheffczik studied chemistry with a focus on biochemistry and earned his doctorate at the Institute of Virology at Philipps University in Marburg. After holding various development and management positions at international research-based pharmaceutical companies, he joined Aenova in 2021, initially as Head of Manufacturing Science & Technology.
"With Dr. Scheffczik we have a long-standing experienced manager and expert who knows the industry and Aenova very well," commented Jan Kengelbach, CEO of Aenova.
Hanno Scheffczik, Managing Director, Temmler Pharma (a member of the Aenova Group). Source: Aenova Group
